Literature DB >> 12664271

Impact of postpartum depressive symptoms on mother and her 18-month-old infant.

Marion Righetti-Veltema1, Arnaud Bousquet, Juan Manzano.   

Abstract

BACKGROUND: Postpartum depression (PPD) is known to have important negative effects on mother, infant and mother-child relationship.
METHODS: We present a case-control study of 35 mothers and their 18-month-old infants. These mothers suffered from postpartum depressive symptoms (PDS) when the infants were three months old, as rated with the Edinburgh Postnatal Depression Scale (EPDS, Cox 1987). A control group of 35 mothers without postpartum depressive symptoms (NPDS) with their 18-month-old infants was also evaluated. The infants were assessed using the Infant Behavior Record of the Bayley Scales of Infant Development, the Strange Situation and an object concept task.
RESULTS: 15 months later, the PDS mothers were less affectionate and more anxious than the NPDS mothers. The PDS dyads demonstrated less verbal interaction and less playing interaction. 18-month-old infants of PDS mothers performed less well on object concept tasks, and were more often insecurely attached to their mothers. Only some results were linked to the mothers' depressive state (D-mothers) diagnosed at 18 months (e. g. responsiveness to persons).
CONCLUSIONS: The important negative effects observed at 18 months on mother and infant of maternal PDS at 3 months confirm the need for early identification and therapeutic or preventive interventions.

Entities:  

Mesh:

Year:  2003        PMID: 12664271     DOI: 10.1007/s00787-003-0311-9

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  38 in total

1.  Emotion (Dys)regulation and Links to Depressive Disorders.

Authors:  Maria Kovacs; Jutta Joormann; Ian H Gotlib
Journal:  Child Dev Perspect       Date:  2008-12-01

2.  Continuing education module: postpartum maternal health care in the United States: a critical review.

Authors:  Ching-Yu Cheng; Eileen R Fowles; Lorraine O Walker
Journal:  J Perinat Educ       Date:  2006

Review 3.  Focusing on the positive: a review of the role of child positive affect in developmental psychopathology.

Authors:  Molly Davis; Cynthia Suveg
Journal:  Clin Child Fam Psychol Rev       Date:  2014-06

Review 4.  Effects of opioids on the parental brain in health and disease.

Authors:  James E Swain; S Shaun Ho; Helen Fox; David Garry; Susanne Brummelte
Journal:  Front Neuroendocrinol       Date:  2019-05-22       Impact factor: 8.606

Review 5.  The maternal reward system in postpartum depression.

Authors:  Caitlin Post; Benedetta Leuner
Journal:  Arch Womens Ment Health       Date:  2018-12-15       Impact factor: 3.633

6.  Early postpartum resting-state functional connectivity for mothers receiving buprenorphine treatment for opioid use disorder: A pilot study.

Authors:  James E Swain; S Shaun Ho
Journal:  J Neuroendocrinol       Date:  2019-07-29       Impact factor: 3.627

Review 7.  Prevalence of Perinatal Depression in the Military: A Systematic Review of the Literature.

Authors:  Stacey L Klaman; Kea Turner
Journal:  Matern Child Health J       Date:  2016-11

8.  Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine.

Authors:  Monica S Paz; Lynne M Smith; Linda L LaGasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2008-12-03       Impact factor: 3.763

9.  Functional status outcomes in mothers with and without postpartum depression.

Authors:  Bobbie Posmontier
Journal:  J Midwifery Womens Health       Date:  2008 Jul-Aug       Impact factor: 2.388

10.  Postpartum depression screening at well-child visits: validity of a 2-question screen and the PHQ-9.

Authors:  Dwenda Gjerdingen; Scott Crow; Patricia McGovern; Michael Miner; Bruce Center
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.